Cited by 461Cancer Research and TreatmentsMicrobial Metabolic Engineering and BioproductionCRISPR and Genetic Engineering

Engineering bacteria for diagnostic and therapeutic applications

Riglar, David T., Silver, Pamela A.·2018·Nature Reviews Microbiology

Abstract

Our ability to generate bacterial strains with unique and increasingly complex functions has rapidly expanded in recent times. The capacity for DNA synthesis is increasing and costing less; new tools are being developed for fast, large-scale genetic manipulation; and more tested genetic parts are available for use, as is the knowledge of how to use them effectively. These advances promise to unlock an exciting array of 'smart' bacteria for clinical use but will also challenge scientists to better optimize preclinical testing regimes for early identification and validation of promising strains and strategies. Here, we review recent advances in the development and testing of engineered bacterial diagnostics and therapeutics. We highlight new technologies that will assist the development of more complex, robust and reliable engineered bacteria for future clinical applications, and we discuss approaches to more efficiently evaluate engineered strains throughout their preclinical development.

Integrity signals

Registry

Crossref · 10.1038/nrmicro.2017.172

Cites

157 of 157 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Cells can be designed to secrete drugs or catalyze key biological reactions, so they can be used as warehouses for drug factories.

    “Cells can also be designed to secrete drugs or catalyze key biological reactions, so they can be used as warehouses for drug factories.326”

    From Smart nanoparticles for cancer therapy (2023) · cites this paper as [326]

Cites

Flagged first, then by citations

1 of the 158 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Riglar, D. T., & Silver, P. A.
Affiliations
Harvard University (US)
Corresponding author
Silver, Pamela A.
Venue
Nature Reviews Microbiology
Published
2018-02-05
Volume
16
Issue
4
Pages
214-225
ISSN
  • 1740-1526 (ISSN-L)
  • 1740-1534
OpenAlex
W2786946130
Cited by
460
References
158
Citations by year
2026: 69 · 2025: 83 · 2024: 65 · 2023: 59 · 2022: 48 · 2021: 51 · 2020: 43 · 2019: 29 · 2018: 13
FWCI
4.01
Type
journal article
Language
en
Open access
closed
Locations
  • Nature Reviews Microbiology (publishedVersion)
  • PubMed (publishedVersion)
  • Spiral (Imperial College London) (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Cancer Research and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Microbial Metabolic Engineering and Bioproduction
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
Keywords
engineered bacteria, synthetic biology, bacterial therapeutics, bacteriological diagnosis, clinical translation, preclinical testing, genetic parts, DNA synthesis
MeSH terms
Animals, Bacteria, Genetic Engineering, Humans, Drug Design, Gene Expression Regulation, Bacterial, Genome, Bacterial

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review